Skip to main content

Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry

CBE ID
0379
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 years and older, seen within a 12 month reporting period, with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period who had baseline flow cytometry studies performed and documented in the chart

        • 1.14 Numerator

          Patients who had baseline flow cytometry studies performed and documented in the chart

        • 1.15 Denominator

          All patients aged 18 years and older, seen within a 12 month reporting period, with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period

        • Exclusions

          For Claims/Registry:

          Documentation of medical reason(s) for not performing baseline flow cytometry studies

          Documentation of patient reason(s) for not performing baseline flow cytometry studies (eg, receiving palliative care or not receiving treatment as defined above)

          Documentation of system reason(s) for not performing baseline flow cytometry studies (eg, patient previously treated by another physician at the time baseline flow cytometry studies were performed)

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Cancer Fall Cycle 2017
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          American Society of Hematology
          Steward Organization POC Email